BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11186718)

  • 1. [Relationship between immunogenic markers with metabolic processes in chronic pyelonephritis].
    Zhmurov VA; Oskolkov SA; Malishevskiĭ MV; Sazonova EV; Mel'nikov AA
    Urologiia; 2000; (3):9-13. PubMed ID: 11186718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Essential phospholipids in the treatment of chronic pyelonephritis].
    Ovchinnikov AA; Tsvettsikh VE; Berdichevskiĭ BA; Lykov VN; Suktanbaev VR; Murychev AV
    Urol Nefrol (Mosk); 1996; (4):7-9. PubMed ID: 8928353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical value of typing antigens of the HLA system in patients with pyelo- and glomerulonephritis].
    Drannik GN; Maĭdannik VG; Montag TS; Bagdasarova IV; Ishchenko EM
    Vrach Delo; 1988 Apr; (4):9-12. PubMed ID: 3165231
    [No Abstract]   [Full Text] [Related]  

  • 4. [Membrane-destabilizing processes as the universal basis of inflammation].
    Tsvettsik VE; Rodoman VE; Zhmurov VA; Krylov VI; Lerner GIa; Berdichevskiĭ BA; Kazeko NI; Ovchinnikov AA
    Urol Nefrol (Mosk); 1994; (2):16-9. PubMed ID: 8016997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lipids content in renal tissue membranes in patients with urolithiasis and secondary pyelonephritis].
    Kazeko NI; Zhmurov VA; Borovskiĭ AA; Veshkurtsev VV; Khvan OV
    Urologiia; 2005; (5):56-8. PubMed ID: 16281843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lipid peroxidation in patients with nephrolithiasis and chronic pyelonephritis in the remission stage].
    Golovanov SA; Drozhzheva VV
    Urol Nefrol (Mosk); 1995; (2):21-2. PubMed ID: 7785114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The enzyme function of cationic transmembrane transport and its relationship to the homeostatic indices of patients with chronic pyelonephritis].
    Tsvetsikh VE; Krylov VI; Lerner GIa; Kazeko NI; Ovchinnikov AA; Berdichevskiĭ BA; Sultanbaev RA; Lykov VN
    Urol Nefrol (Mosk); 1991; (1):48-50. PubMed ID: 1830430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipid peroxidation and transmembrane transport in patients with chronic pyelonephritis].
    Tsvettsikh VE
    Urol Nefrol (Mosk); 1989; (6):31-4. PubMed ID: 2617735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urinary excretion of glycosaminoglycans in patients with chronic pyelonephritis and chronic glomerulonephritis].
    Pavlov SB
    Klin Med (Mosk); 1998; 76(2):41-3. PubMed ID: 9553361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunogenetic aspects of pathogenesis, prognosis and treatment of the main forms of chronic pancreatitis].
    Gubergrits NB; Khodakovskii AV; Linevskii IV
    Klin Med (Mosk); 1996; 74(7):26-8. PubMed ID: 8992107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The importance of studies of calcium reabsorption and of the capacity of the blood plasma to inhibit Ca-ATPase activity for the diagnosis of the activity of the inflammatory process and for the prognosis of tubular function in patients with chronic pyelonephritis].
    Golod EA; Onishchenko NA
    Urol Nefrol (Mosk); 1994; (2):19-22. PubMed ID: 8016998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipid peroxidation and Ca-dependent ATPase activity in the microsomal fraction of renal tissue in patients with nephrolithiasis and chronic pyelonephritis].
    Golod EA
    Urol Nefrol (Mosk); 1996; (5):14-6. PubMed ID: 9054096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lipid peroxidation in the kidney tissue of patients with nephrolithiasis and chronic pyelonephritis].
    Golod EA; Darenkov AF; Kirpatovskiĭ VI; Ianenko EK
    Urol Nefrol (Mosk); 1995; (5):8-10. PubMed ID: 8571492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The immune status of patients with primary and secondary chronic pyelonephritis].
    al-Shukri SKh; Gorbachev AG; Smironov VS; Kuz'min IV
    Urol Nefrol (Mosk); 1996; (3):17-20. PubMed ID: 8928323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-kidney antibodies in patients with chronic pyelonephritis].
    Goligorskiĭ SD; Sokolov AV; Pavlova LP; Baĭlo VD; Chernyshov VP
    Urol Nefrol (Mosk); 1971; 36(5):17-9. PubMed ID: 5142015
    [No Abstract]   [Full Text] [Related]  

  • 16. [The clinical significance of immunological indices in chronic pyelonephritis].
    Shulutko BI; Kulaeva NN; Ambrozas IV; Shumilkin VR; Anikonova LI
    Ter Arkh; 1993; 65(6):11-3. PubMed ID: 8378837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of allergic leukocytolysis with renal and pelvic antigens in the dynamics of pyelonephritis in children].
    Gaevskaia AV
    Pediatr Akus Ginekol; 1975; (2):21-2. PubMed ID: 1128935
    [No Abstract]   [Full Text] [Related]  

  • 18. [Impact of interference currents on lipid peroxidation in children with chronic pyelonephritis].
    Khan MA; Sergeeva TV; Novikova EV
    Vopr Kurortol Fizioter Lech Fiz Kult; 2002; (4):33-4. PubMed ID: 12380531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinical significance of connective tissue metabolism and of cellular and humoral factors in chronic pyelonephritis].
    Alekseev VA
    Ter Arkh; 1991; 63(6):46-8. PubMed ID: 1948745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of interference currents and iodobromine baths in the therapy of patients with chronic nonobstructive pyelonephritis].
    Nesterov NI; Kiiatkin VA; Li AA; Derevnina NA
    Vopr Kurortol Fizioter Lech Fiz Kult; 1996; (5):19-22. PubMed ID: 9036659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.